Acer Therapeutics (ACER) Misses Q1 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Acer Therapeutics (ACER) PT Raised to $51 at Brookline Capital Markets
August 15, 2018 11:52 AM EDTBrookline Capital Markets analyst Kumaraguru Raja raised the price target on Acer Therapeutics (NASDAQ: ACER) to $51.00 while maintaining a Buy rating.
Raja notes the company is on track for NDA filing for EDSIVO in vEDS in Q4 following pre-NDA meeting.
... More